Paper7300874
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.
Knowles M and 2 others. N Engl J Med, 1981. Cited by 519 papers, by iCite.
Cite this record
ConductScience Library. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. Papers, record 7300874. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7300874
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Respiratory System | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Amiloride | |
| Bronchi | |
| Child | |
| Child, Preschool | |
| Epithelium | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Membrane Potentials | |
| Middle Aged | |
| Nasal Mucosa |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL 16674 | NHLBI NIH HHS | United States | R01HL016674 | PubMed and NIH | NIH RePORTER |
| HL 22924 | NHLBI NIH HHS | United States | R01HL022924 | PubMed and NIH | NIH RePORTER |
| RR-46 | NCRR NIH HHS | United States | PubMed | PubMed |
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 519 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41081806 | Acquired cystic fibrosis transmembrane conductance regulator dysfunction. | Pflugers Arch | 2025 | https://conductscience.org/library/papers/41081806 | PubMed |
| 40932259 | Cystic fibrosis: Correction of a fatal disease. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40932259 | PubMed |
| 40320452 | Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators. | Mol Cell Pediatr | 2025 | https://conductscience.org/library/papers/40320452 | PubMed |
| 39273547 | Cystic Fibrosis: A Journey through Time and Hope. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273547 | PubMed |
| 39244603 | A case study of the informative value of risk of bias and reporting quality assessments for systematic reviews. | Syst Rev | 2024 | https://conductscience.org/library/papers/39244603 | PubMed |
| 37843282 | Puzzle resolved: CFTR mediates chloride homeostasis by segregating absorption and secretion to different cell types. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37843282 | PubMed |
| 37835841 | A Systematic Review of the Effect of Cystic Fibrosis Treatments on the Nasal Potential Difference Test in Animals and Humans. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37835841 | PubMed |
| 37265479 | Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes? | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37265479 | PubMed |
| 35148101 | Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology. | J Med Chem | 2022 | https://conductscience.org/library/papers/35148101 | PubMed |
| 34857676 | S-nitrosothiols signaling in cystic fibrosis airways. | J Biosci | 2021 | https://conductscience.org/library/papers/34857676 | PubMed |
| 34799640 | Measurements of spontaneous CFTR-mediated ion transport without acute channel activation in airway epithelial cultures after modulator exposure. | Sci Rep | 2021 | https://conductscience.org/library/papers/34799640 | PubMed |
| 34437820 | Cystic Fibrosis and the Cells of the Airway Epithelium: What Are Ionocytes and What Do They Do? | Annu Rev Pathol | 2022 | https://conductscience.org/library/papers/34437820 | PubMed |
| 34385926 | Assessment of Lentiviral Vector Mediated CFTR Correction in Mice Using an Improved Rapid in vivo Nasal Potential Difference Measurement Protocol. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34385926 | PubMed |
| 34084147 | Single-Dose Lentiviral Mediated Gene Therapy Recovers CFTR Function in Cystic Fibrosis Knockout Rats. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34084147 | PubMed |
| 33923202 | Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33923202 | PubMed |
| 33569494 | First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers. | ERJ Open Res | 2021 | https://conductscience.org/library/papers/33569494 | PubMed |
| 33533914 | Large pH oscillations promote host defense against human airways infection. | J Exp Med | 2021 | https://conductscience.org/library/papers/33533914 | PubMed |
| 33319831 | K2P2.1 (TREK-1) potassium channel activation protects against hyperoxia-induced lung injury. | Sci Rep | 2020 | https://conductscience.org/library/papers/33319831 | PubMed |
| 33232302 | Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene. | JCI Insight | 2021 | https://conductscience.org/library/papers/33232302 | PubMed |
| 33208364 | Engineered mutant α-ENaC subunit mRNA delivered by lipid nanoparticles reduces amiloride currents in cystic fibrosis-based cell and mice models. | Sci Adv | 2020 | https://conductscience.org/library/papers/33208364 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7300874
GET https://conductscience.org/api/papers/v1/7300874/cited_by?page=2